文献速递角膜与眼表疾病

莫拉菌性角膜炎:危险因素、临床特征、治疗与结局分析

Moraxella Keratitis: Analysis of Risk Factors, Clinical Characteristics, Management, and Treatment Outcomes.
PubMed 文献 · Am J Ophthalmol · 2018-09-08

回顾性分析39例培养证实的莫拉菌性角膜炎,87.2%存在眼部危险因素,最常见为睑缘炎和干眼(各30.8%),92.3%使用氟喹诺酮,10.3%需睑缘缝合,15.4%需穿透性角膜移植,54.3%最终视力为指数或更差。

要点

  • 多数莫拉菌性角膜炎患者存在眼部危险因素,尤其是眼表条件差。
  • 分离菌株对氟喹诺酮和氨基糖苷类敏感,耐药少见。
  • 不少患者需手术干预,最终视力常较差。

核心结论

  • 莫拉菌性角膜炎患者绝大多数存在眼部危险因素,尤其是眼表条件差。
  • 本研究中莫拉菌分离株对氟喹诺酮和氨基糖苷类敏感。
  • 许多患者需要手术干预,最终视力常较差。

研究设计与样本

  • 回顾性观察性病例系列,纳入2003年1月至2018年4月在UPMC诊断治疗的39例培养证实的莫拉菌性角膜炎(39眼)。

主要发现

  • 39例患者平均年龄63.0岁(范围4-95岁),中位随访170天。
  • 8例(20.5%)有糖尿病史。
  • 对氟喹诺酮、庆大霉素和妥布霉素耐药各1例。

关键数值与推荐

  • 4例(10.3%)需睑缘缝合,6例(15.4%)需穿透性角膜移植,1例需眼球摘除。
  • 35例有视力信息者中,19例(54.3%)最近随访视力为指数或更差。

临床怎么用

  • 对莫拉菌性角膜炎应评估并处理眼部危险因素,尤其是眼表疾病。
  • 氟喹诺酮和氨基糖苷类可作为治疗选择,但需注意耐药可能。
  • 部分患者可能需手术干预,应告知视力预后可能较差。

局限性

  • 回顾性观察性病例系列,样本量39例,来自单中心。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To analyze the risk factors, clinical characteristics, management, and treatment outcomes of culture-proven cases of Moraxella keratitis at our center. DESIGN: Retrospective observational case series. METHODS: Thirty-nine culture-proven cases of Moraxella keratitis (39 eyes) diagnosed and treated between January 2003 and April 2018 at the University of Pittsburgh Medical Center were identified and retrospectively reviewed for ocular and systemic risk factors, treatment modalities, and outcomes, as well as for antimicrobial sensitivity and resistance data. RESULTS: The mean age of the 39 patients was 63.0 (range 4-95 years) with median follow-up time of 170 days. Thirty-four of 39 patients (87.2%) had an ocular risk factor, the most common of which were blepharitis in 12 (30.8%), dry eyes in 12 (30.8%), and history of ocular surgery in 9 (23.1%). History of diabetes mellitus was found in 8 patients (20.5%). Thirty-six of 39 patients (92.3%) received a fluoroquinolone (92.3%) and 30 of 39 (76.7%) received topical fortified antibiotics. Resistance to fluoroquinolones, gentamicin, and tobramycin was seen in 1 patient each, respectively. Four patients (10.3%) required tarsorrhaphy, 6 patients (15.4%) required penetrating keratoplasty, and 1 patient required enucleation. Of the 35 patients for whom visual acuity information was available, 19 (54.3%) were count fingers or worse at most recent follow-up. CONCLUSIONS: Ocular risk factors, especially poor ocular surface, were identified in the vast majority of patients with Moraxella keratitis. Moraxella isolates in our study were susceptible to fluoroquinolones and aminoglycosides. Many patients required surgical intervention and the final visual acuity was often poor.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Durrani AF, Faith SC, Kowalski RP, et al. Moraxella Keratitis: Analysis of Risk Factors, Clinical Characteristics, Management, and Treatment Outcomes. Am J Ophthalmol. 2018. PMID: 30201340. doi:10.1016/j.ajo.2018.08.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。